Kristie Neo (DealStreetAsia) posted on 28 Jun 2021
Temasek-backed Vertex Growth Fund expects to hit the first close of its $330-million second fund by next month, according to a senior executive at the firm.
Click here to find out more.
Allay Therapeutics, a clinical-stage biotech start-up that makes pain relief products, raised US$60 million (S$80.45 million) in a Series C fund-raising round led by United States-based healthcare-focused venture capital firm Arboretum Ventures. Temasek, Temasek's subsidiary Pavilion Capital, as well as Temasek-linked Vertex Growth and Vertex Ventures HC participated in the round; there was no shortage of other crossover investors, including from Australia and Taiwan. Other investors included US-based NEA, Australian life science investor Brandon Capital Partners and WTT Investment, the Taiwan-based single family office of Fubon Group founder Tsai Wan-Tsai.
Sunday, an insurtech startup based in Bangkok, announced it has raised a $45 million Series B. Investors include Tencent, SCB 10X, Vertex Growth, Vertex Ventures Southeast Asia & India, Quona Capital, Aflac Ventures and Z Venture Capital. The company says the round was oversubscribed, and that it doubled its revenue growth in 2020.
Beijing-based AI solution provider Horizon Robotics launched on July 29 its new-generation smart driving chip “Journey 5”. The full-scenario intelligent complete vehicle solution and computing platform built on the newly-launched chip were unveiled at the same time. The Journey 5 chip is Horizon Robotics' third-generation automotive-grade AI chip following the Journey 2 and the Journey 3.